MARATTO

article · Benha Journal of Applied Sciences

Premature Ejaculation .Bulbospongius Muscle injection by Botox 100IU (Anatomic Basis and Clinical Effect)

Abstract

Background: Premature Male incontinence is characterised by ejaculation. There is no specific treatment for this illness. Our goal is to look at how individuals with PE who had botulinum-A toxin injections into their bulbospongiosus muscles fared after treatment. Methods: Through percutaneous endovascular injection, ninety outpatients inject five centilitres of botulinum-A toxin diluted with ten centilitres of saline into the bulbospongiosus muscle on each side (PE). The patients were assessed using the Premature Ejaculation Profile scores in conjunction with the intravaginal ejaculatory latency time (IELT) (PEP). Checks again one, three, and six months after the procedure. Without any adverse effects, patients were able to increase their intravaginal ejaculatory delay duration and enhance their PEP score relative to their pretreatment performance. Conclusions. injection A safe and effective method for treating PE involves injecting botulinum toxin into the bulbospongiosus muscle.

Research topics

  • Botulinum Toxin and Related Neurological Disorders

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.21608/bjas.2024.267702.1317

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.